Interestingly, incubation of a P-selectin inhibitor with whole blood from patients with COVID-19 significantly reduced the interactions of platelets with granulocytes and monocytes but not with lymphocytes, which express less P-selectin glycoprotein ligand-1. This evidence concerns the gene SELP and COVID-19.